Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy

Artificial Cells, Nanomedicine and Biotechnology

Volumn 42, Issue 6, 2014, Pages 406-412

  Parnami, Nupur ^a   Garg, Tarun ^a   Rath, Goutam ^a   Goyal, Amit K ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Immunosuppressant; Orthokeratosis; Photodynamic therapy; Psoriasis

Indexed keywords

BLOOD VESSELS; DERMATOLOGY; DISEASE CONTROL; DRUG THERAPY; SKIN;

COMBINATION THERAPY; EXPERIMENTAL ANIMALS; IMMUNOSUPPRESSANT; IMMUNOSUPPRESSANTS; NONINVASIVE TECHNIQUE; ORTHOKERATOSIS; PSORIASIS; TOPICAL TREATMENTS;

PHOTODYNAMIC THERAPY;

METHOTREXATE; NANOCARRIER; TRIOXYSALEN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHOTOTHERAPY; PHYSICAL CHEMISTRY; PSORIASIS; RAT; TOPICAL TREATMENT; ULTRAVIOLET RADIATION;

ANIMALIA;

EID: 84964255511     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2013.837474     Document Type: Article

References (19)

1. Ali MF , Salah M, Rafea M, Saleh N. 2008. Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting. Med Sci Monit. 14: PI66-74.
2. Almutawa F , Alnomair N , Wang Y , Hamzavi I, Lim HW. 2013. Systematic review of UV-based therapy for psoriasis. Am J Clin Dermatol. 14 : 87-109.
3. Azeem A , Khan ZI , Aqil M , Ahmad FJ , Khar RK , Talegaonkar S. 2009. Microemulsions as a surrogate carrier for dermal drug delivery Drug Dev Ind Pharm. 35: 525-547.
4. Brady SP. 2004. Parakeratosis. J Am Acad Dermatol. 50 : 77-84.
5. Dayal S , Jain VK. 2010. Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis. Indian J Dermatol Venereol Leprol. 76 : 533-537.
6. Dogra S , Krishna V , Kanwar AJ. 2012. Effi cacy and safety of systemic methotrexate in two fi xed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study. Clin Exp Dermatol. 37 : 729-734.
7. Dubey V , Mishra D , Dutta T , Nahar M , Saraf DK , Jain NK. 2007. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release. 123 : 148-154.
8. Garg T , Singh O , Arora S , Murthy R. 2012. Scaff old: a novel carrier for cell and drug delivery. Crit Rev Th er Drug Carrier Syst. 29: 1-63.
9. Hashizume H, Ito T , Yagi H, Takigawa M, Kageyama H, Furukawa F , et al. 2007. Effi cacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris. J Dermatol. 34: 430-434.
10. Ko YT , Bickel U. 2012. Liposome-encapsulated polyethylenimine/oligonucleotide polyplexes prepared by reverse-phase evaporation technique. AAPS PharmSciTech. 13 : 373-378.
11. Kocak AY , Kocak O , Aslan F , Tektas M. 2013. Methotrexate toxicity presenting as cutaneous ulcerations on psoriatic plaques. Cutan Ocul Toxicol. 32 : 333-335.
12. Lotti TM. 2008. Dermatologic therapy issue on " New and emerging treatments in dermatology " , Dermatol Ther. 21 : 85.
13. Lunter D , Daniels R. 2013. In vitro skin permeation and penetration of nonivamide from novel fi lm-forming emulsions. Skin Pharmacol Physiol. 26: 139-146.
14. Mason AR, Mason J , Cork M, Dooley G , Hancock H. 2013. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev. 3: CD005028.
15. Nagle A , Goyal AK , Kesarla R, Murthy RR. 2011. Effi cacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model. J Liposome Res. 21 : 134-140.
16. Sebok B , Bonnekoh B , Kerenyi M , Gollnick H. 2000. Tazarotene induces epidermal cell diff erentiation in the mouse tail test used as an animal model for psoriasis. Skin Pharmacol Appl Skin Physiol. 13 : 285-291.
17. Shirsand S , Para M, Nagendrakumar D , Kanani K , Keerthy D. 2012. Formulation and evaluation of Ketoconazole niosomal gel drug delivery system. Int J Pharm Investig. 2: 201-207.
18. Silva FS , Oliveira H, Moreiras A , Fernandes JC , Bronze-da-Rocha E , Figueiredo A , et al. 2013. Cytotoxic and genotoxic eff ects of acitretin, alone or in combination with psoralen-ultraviolet A or narrow-band ultraviolet B-therapy in psoriatic patients , Mutat Res. 753 : 42-47.
19. Ruchusatsawat K , Wongpiyabovorn J , Protjaroen P , Chaipipat M, Shuangshoti S , Th orner PS , Mutirangura A. 2011. Parakeratosis in skin is associated with loss of inhibitor of diff erentiation 4 via promoter methylation. Hum Pathol. 42 : 1878-1887.